Results 81 to 90 of about 74,283 (261)

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction [PDF]

, 2019
Examination of cross-protection and type replacement after human papillomavirus (HPV) vaccine introduction is essential to guide vaccination recommendations and policies.
Bernstein, David I., Brown, Darron, Covert, Courtney, Ding, Lili, Franco, Eduardo L., Kahn, Jessica A.   +5 more
core   +1 more source

Nationwide Study on the Cervical Cancer Screening Pathway in Estonia

International Journal of Cancer, EarlyView.
Cervical cancer remains a significant burden despite being preventable, largely due to inadequate screening participation and poor follow‐up of high‐risk women. Here, the authors investigated follow‐up rates among women who tested positive for high‐risk human papillomavirus (hr‐HPV) infection in primary screening in Estonia. Data show that more than 57
Aleksandra Šavrova, Helen Jakoby, Anna Tisler, Kaire Innos, Ülo Maiväli, Jana Jaal, Anneli Uusküla   +6 more
wiley   +1 more source

Applying Multiple Data Collection Tools to Quantify Human Papillomavirus Vaccine Communication on Twitter. [PDF]

, 2016
BACKGROUND: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. There are several vaccines that protect against strains of HPV most associated with cervical and other cancers.
Budenz, Alexandra, Fisher, Kara, Klassen, Ann C., Leader, Amy, Massey, Philip M., Yom-Tov, Elad   +5 more
core   +3 more sources

Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?

Human Vaccines & Immunotherapeutics, 2021
HPV vaccination is recommended for U.S. adolescents at ages 11–12 and requires two versus three doses if the series is started before age 15. We evaluated how talking about recommended age or fewer doses motivates on-time HPV vaccination.
Marjorie A. Margolis, Noel T. Brewer, Parth D. Shah, William A. Calo, Susan Alton Dailey, Melissa B. Gilkey   +5 more
doaj   +1 more source

Awareness of Human Papillomavirus (HPV), Increasing Rates of Oropharyngeal Cancer, and Estimated Economic Burden in Denmark

International Journal of Cancer, EarlyView.
Human papillomavirus (HPV) is a highly prevalent sexually transmitted infection. This comprehensive assessment of HPV public awareness in Denmark shows that despite the high national HPV vaccination coverage and growing public health focus on HPV‐related diseases, more than one‐third of survey respondents had never heard of HPV and fewer than 40 ...
Kathrine Kronberg Jakobsen, Umar Rehman, Christian Grønhøj, Zi Jian Lau, Jens Peter Klussmann, Matt Lechner, Christian von Buchwald   +6 more
wiley   +1 more source

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland [PDF]

, 2014
In Scotland, a national HPV immunisation programme began in 2008 for 12-13 year olds, with a catch-up campaign from 2008-2011 for those under the age of 18.
A Potts, AR Kreimer, B Baldur-Felskov, B Romanowski, C Robertson, CM Wheeler, D Baker, E Crowe, H Cubie, HL Bowyer, J Love, J Paavonen, JML Brotherton, JS Smith, K Cuschieri, K Cuschieri, K G J Pollock, K Kavanagh, K Kavanagh, K Kavanagh, K Sinka, L Henderson, LAV Marlow, M Cruickshank, M Donaghy, MC O’Leary, RS Bhopal, S Nicoll, SE Powell, T J Palmer, T Malagon, TG Hopkins   +31 more
core   +4 more sources

Health Care Policy Implementation Trial of Primary Human Papillomavirus–Based Cervical Screening in Denmark

International Journal of Cancer, EarlyView.
Uncertainty has persisted over whether human papillomavirus (HPV) testing outperforms high‐quality cytology in real‐world cervical cancer screening programs. To address this, Denmark launched a nationwide trial in 2021, implementing an HPV‐based screening strategy using specialized algorithms integrated with molecular and cytology triage to optimize ...
Jesper Bonde, Jeppe Bennekou Schroll, Birgitte Tønnes Pedersen, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Frandsen, Rikke Holst Andersen, Susanne Nielsen, Doris Schledermann, Bettina Kjær Kristensen, Berit Andersen, on behalf of the National Danish Cervical Cancer Screening Steering Committee   +12 more
wiley   +1 more source

Secondary school girls' knowledge and practice on human papillomavirus (HPV), cervical cancer and human papillomavirus (HPV) vaccination in Kuantan, Pahang, Malaysia

MRIMS Journal of Health Sciences, 2017
Background: Cervical cancer becomes the second leading cancer in Malaysia and HPV infection is the main cause of this cancer. The availability of HPV vaccination can reduce down the risk of getting HPV infection thus will also reduce incidence of ...
Khin Thandar Aung, Nurul Syafiqa Binti Md Merzuki, Cho Cho Zaw Rahemma   +2 more
doaj   +1 more source

HPV‐Related Cancers in Solid Organ Transplant Recipients: A Nationwide Danish Cohort Study

International Journal of Cancer, EarlyView.
Solid organ transplant recipients (SOTRs) face chronic immunosuppression, leaving them susceptible to viral infections. Of particular concern is persistent infection with human papillomavirus (HPV), which presents a significant cancer risk. This nationwide Danish cohort study estimated cancer risk in SOTRs using health registry data.
Signe Timm, Flemming Skjøth, Torben Frøstrup Hansen, Lars Henrik Jensen, Paw Christian Holdgaard, Lars Ulrik Fokdal, Torben Bjerregaard Larsen, Mette Moeller Soerensen   +7 more
wiley   +1 more source

Barriers and facilitators to HPV vaccination in primary care practices: A mixed methods study using the Consolidated Framework for Implementation Research [PDF]

, 2018
Background In the United States, the effective, safe huma papilloma virus (HPV) vaccine is underused and opportunities to prevent cancer continue to be missed.
Dodd, Sherry, Garbutt, Jane M, Kulka, Katharine, Lee, Amanda A, Lobb, Rebecca, Walling, Emily   +5 more
core   +2 more sources